Global mRNA Vaccine Raw Materials Market Research Report 2025(Status and Outlook)

March 2025 | 183 pages | ID: GBC9CEE1A923EN
Bosson Research

Abstracts

Report Overview

The development and production of mRNA vaccines is relatively simple, scalable, and extremely rapid. mRNA is produced in vitro through an enzymatic process without the need to remove cells or host cell proteins. This simplified production process allows GMP facilities to be converted to produce new protein targets in a very short period of time, with only minimal changes to the process and formulation.

This report provides a deep insight into the global mRNA Vaccine Raw Materials market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccine Raw Materials Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccine Raw Materials market in any manner.

Global mRNA Vaccine Raw Materials Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Thermo Fisher Scientific Inc.

Danaher Corporation

Kaneka Eurogentec S.A.

BioSpring

GenScript

Aji Bio-Pharma

Merck KGaA

Aldevron

Hongene

WuXi Biologics

Asymchem

Cosychem

Novoprotein

Vazyme

Yeasen

KACTUS

Market Segmentation (by Type)

Plasmid DNA (pDNA)

Enzyme

Other

Market Segmentation (by Application)

(non-replicating) mRNA vaccine

(self-amplifying) mRNA vaccine

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the mRNA Vaccine Raw Materials Market
• Overview of the regional outlook of the mRNA Vaccine Raw Materials Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccine Raw Materials Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of mRNA Vaccine Raw Materials
1.2 Key Market Segments
  1.2.1 mRNA Vaccine Raw Materials Segment by Type
  1.2.2 mRNA Vaccine Raw Materials Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MRNA VACCINE RAW MATERIALS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global mRNA Vaccine Raw Materials Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global mRNA Vaccine Raw Materials Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MRNA VACCINE RAW MATERIALS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global mRNA Vaccine Raw Materials Product Life Cycle
3.3 Global mRNA Vaccine Raw Materials Sales by Manufacturers (2020-2025)
3.4 Global mRNA Vaccine Raw Materials Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Vaccine Raw Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Vaccine Raw Materials Average Price by Manufacturers (2020-2025)
3.7 Manufacturers mRNA Vaccine Raw Materials Manufacturing Sites, Area Served, Product Type
3.8 mRNA Vaccine Raw Materials Market Competitive Situation and Trends
  3.8.1 mRNA Vaccine Raw Materials Market Concentration Rate
  3.8.2 Global 5 and 10 Largest mRNA Vaccine Raw Materials Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MRNA VACCINE RAW MATERIALS INDUSTRY CHAIN ANALYSIS

4.1 mRNA Vaccine Raw Materials Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINE RAW MATERIALS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global mRNA Vaccine Raw Materials Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to mRNA Vaccine Raw Materials Market
5.7 ESG Ratings of Leading Companies

6 MRNA VACCINE RAW MATERIALS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccine Raw Materials Sales Market Share by Type (2020-2025)
6.3 Global mRNA Vaccine Raw Materials Market Size Market Share by Type (2020-2025)
6.4 Global mRNA Vaccine Raw Materials Price by Type (2020-2025)

7 MRNA VACCINE RAW MATERIALS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccine Raw Materials Market Sales by Application (2020-2025)
7.3 Global mRNA Vaccine Raw Materials Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Vaccine Raw Materials Sales Growth Rate by Application (2020-2025)

8 MRNA VACCINE RAW MATERIALS MARKET SALES BY REGION

8.1 Global mRNA Vaccine Raw Materials Sales by Region
  8.1.1 Global mRNA Vaccine Raw Materials Sales by Region
  8.1.2 Global mRNA Vaccine Raw Materials Sales Market Share by Region
8.2 Global mRNA Vaccine Raw Materials Market Size by Region
  8.2.1 Global mRNA Vaccine Raw Materials Market Size by Region
  8.2.2 Global mRNA Vaccine Raw Materials Market Size Market Share by Region
8.3 North America
  8.3.1 North America mRNA Vaccine Raw Materials Sales by Country
  8.3.2 North America mRNA Vaccine Raw Materials Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe mRNA Vaccine Raw Materials Sales by Country
  8.4.2 Europe mRNA Vaccine Raw Materials Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific mRNA Vaccine Raw Materials Sales by Region
  8.5.2 Asia Pacific mRNA Vaccine Raw Materials Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America mRNA Vaccine Raw Materials Sales by Country
  8.6.2 South America mRNA Vaccine Raw Materials Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa mRNA Vaccine Raw Materials Sales by Region
  8.7.2 Middle East and Africa mRNA Vaccine Raw Materials Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 MRNA VACCINE RAW MATERIALS MARKET PRODUCTION BY REGION

9.1 Global Production of mRNA Vaccine Raw Materials by Region(2020-2025)
9.2 Global mRNA Vaccine Raw Materials Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Vaccine Raw Materials Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Vaccine Raw Materials Production
  9.4.1 North America mRNA Vaccine Raw Materials Production Growth Rate (2020-2025)
  9.4.2 North America mRNA Vaccine Raw Materials Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Vaccine Raw Materials Production
  9.5.1 Europe mRNA Vaccine Raw Materials Production Growth Rate (2020-2025)
  9.5.2 Europe mRNA Vaccine Raw Materials Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Vaccine Raw Materials Production (2020-2025)
  9.6.1 Japan mRNA Vaccine Raw Materials Production Growth Rate (2020-2025)
  9.6.2 Japan mRNA Vaccine Raw Materials Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Vaccine Raw Materials Production (2020-2025)
  9.7.1 China mRNA Vaccine Raw Materials Production Growth Rate (2020-2025)
  9.7.2 China mRNA Vaccine Raw Materials Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Thermo Fisher Scientific Inc.
  10.1.1 Thermo Fisher Scientific Inc. Basic Information
  10.1.2 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Overview
  10.1.3 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Market Performance
  10.1.4 Thermo Fisher Scientific Inc. Business Overview
  10.1.5 Thermo Fisher Scientific Inc. SWOT Analysis
  10.1.6 Thermo Fisher Scientific Inc. Recent Developments
10.2 Danaher Corporation
  10.2.1 Danaher Corporation Basic Information
  10.2.2 Danaher Corporation mRNA Vaccine Raw Materials Product Overview
  10.2.3 Danaher Corporation mRNA Vaccine Raw Materials Product Market Performance
  10.2.4 Danaher Corporation Business Overview
  10.2.5 Danaher Corporation SWOT Analysis
  10.2.6 Danaher Corporation Recent Developments
10.3 Kaneka Eurogentec S.A.
  10.3.1 Kaneka Eurogentec S.A. Basic Information
  10.3.2 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Overview
  10.3.3 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Market Performance
  10.3.4 Kaneka Eurogentec S.A. Business Overview
  10.3.5 Kaneka Eurogentec S.A. SWOT Analysis
  10.3.6 Kaneka Eurogentec S.A. Recent Developments
10.4 BioSpring
  10.4.1 BioSpring Basic Information
  10.4.2 BioSpring mRNA Vaccine Raw Materials Product Overview
  10.4.3 BioSpring mRNA Vaccine Raw Materials Product Market Performance
  10.4.4 BioSpring Business Overview
  10.4.5 BioSpring Recent Developments
10.5 GenScript
  10.5.1 GenScript Basic Information
  10.5.2 GenScript mRNA Vaccine Raw Materials Product Overview
  10.5.3 GenScript mRNA Vaccine Raw Materials Product Market Performance
  10.5.4 GenScript Business Overview
  10.5.5 GenScript Recent Developments
10.6 Aji Bio-Pharma
  10.6.1 Aji Bio-Pharma Basic Information
  10.6.2 Aji Bio-Pharma mRNA Vaccine Raw Materials Product Overview
  10.6.3 Aji Bio-Pharma mRNA Vaccine Raw Materials Product Market Performance
  10.6.4 Aji Bio-Pharma Business Overview
  10.6.5 Aji Bio-Pharma Recent Developments
10.7 Merck KGaA
  10.7.1 Merck KGaA Basic Information
  10.7.2 Merck KGaA mRNA Vaccine Raw Materials Product Overview
  10.7.3 Merck KGaA mRNA Vaccine Raw Materials Product Market Performance
  10.7.4 Merck KGaA Business Overview
  10.7.5 Merck KGaA Recent Developments
10.8 Aldevron
  10.8.1 Aldevron Basic Information
  10.8.2 Aldevron mRNA Vaccine Raw Materials Product Overview
  10.8.3 Aldevron mRNA Vaccine Raw Materials Product Market Performance
  10.8.4 Aldevron Business Overview
  10.8.5 Aldevron Recent Developments
10.9 Hongene
  10.9.1 Hongene Basic Information
  10.9.2 Hongene mRNA Vaccine Raw Materials Product Overview
  10.9.3 Hongene mRNA Vaccine Raw Materials Product Market Performance
  10.9.4 Hongene Business Overview
  10.9.5 Hongene Recent Developments
10.10 WuXi Biologics
  10.10.1 WuXi Biologics Basic Information
  10.10.2 WuXi Biologics mRNA Vaccine Raw Materials Product Overview
  10.10.3 WuXi Biologics mRNA Vaccine Raw Materials Product Market Performance
  10.10.4 WuXi Biologics Business Overview
  10.10.5 WuXi Biologics Recent Developments
10.11 Asymchem
  10.11.1 Asymchem Basic Information
  10.11.2 Asymchem mRNA Vaccine Raw Materials Product Overview
  10.11.3 Asymchem mRNA Vaccine Raw Materials Product Market Performance
  10.11.4 Asymchem Business Overview
  10.11.5 Asymchem Recent Developments
10.12 Cosychem
  10.12.1 Cosychem Basic Information
  10.12.2 Cosychem mRNA Vaccine Raw Materials Product Overview
  10.12.3 Cosychem mRNA Vaccine Raw Materials Product Market Performance
  10.12.4 Cosychem Business Overview
  10.12.5 Cosychem Recent Developments
10.13 Novoprotein
  10.13.1 Novoprotein Basic Information
  10.13.2 Novoprotein mRNA Vaccine Raw Materials Product Overview
  10.13.3 Novoprotein mRNA Vaccine Raw Materials Product Market Performance
  10.13.4 Novoprotein Business Overview
  10.13.5 Novoprotein Recent Developments
10.14 Vazyme
  10.14.1 Vazyme Basic Information
  10.14.2 Vazyme mRNA Vaccine Raw Materials Product Overview
  10.14.3 Vazyme mRNA Vaccine Raw Materials Product Market Performance
  10.14.4 Vazyme Business Overview
  10.14.5 Vazyme Recent Developments
10.15 Yeasen
  10.15.1 Yeasen Basic Information
  10.15.2 Yeasen mRNA Vaccine Raw Materials Product Overview
  10.15.3 Yeasen mRNA Vaccine Raw Materials Product Market Performance
  10.15.4 Yeasen Business Overview
  10.15.5 Yeasen Recent Developments
10.16 KACTUS
  10.16.1 KACTUS Basic Information
  10.16.2 KACTUS mRNA Vaccine Raw Materials Product Overview
  10.16.3 KACTUS mRNA Vaccine Raw Materials Product Market Performance
  10.16.4 KACTUS Business Overview
  10.16.5 KACTUS Recent Developments

11 MRNA VACCINE RAW MATERIALS MARKET FORECAST BY REGION

11.1 Global mRNA Vaccine Raw Materials Market Size Forecast
11.2 Global mRNA Vaccine Raw Materials Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe mRNA Vaccine Raw Materials Market Size Forecast by Country
  11.2.3 Asia Pacific mRNA Vaccine Raw Materials Market Size Forecast by Region
  11.2.4 South America mRNA Vaccine Raw Materials Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of mRNA Vaccine Raw Materials by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global mRNA Vaccine Raw Materials Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of mRNA Vaccine Raw Materials by Type (2026-2033)
  12.1.2 Global mRNA Vaccine Raw Materials Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of mRNA Vaccine Raw Materials by Type (2026-2033)
12.2 Global mRNA Vaccine Raw Materials Market Forecast by Application (2026-2033)
  12.2.1 Global mRNA Vaccine Raw Materials Sales (K MT) Forecast by Application
  12.2.2 Global mRNA Vaccine Raw Materials Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Vaccine Raw Materials Market Size Comparison by Region (M USD)
Table 5. Global mRNA Vaccine Raw Materials Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global mRNA Vaccine Raw Materials Sales Market Share by Manufacturers (2020-2025)
Table 7. Global mRNA Vaccine Raw Materials Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global mRNA Vaccine Raw Materials Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Raw Materials as of 2024)
Table 10. Global Market mRNA Vaccine Raw Materials Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers mRNA Vaccine Raw Materials Manufacturing Sites and Area Served
Table 12. Manufacturers mRNA Vaccine Raw Materials Product Type
Table 13. Global mRNA Vaccine Raw Materials Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. mRNA Vaccine Raw Materials Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global mRNA Vaccine Raw Materials Sales by Type (K MT)
Table 25. Global mRNA Vaccine Raw Materials Market Size by Type (M USD)
Table 26. Global mRNA Vaccine Raw Materials Sales (K MT) by Type (2020-2025)
Table 27. Global mRNA Vaccine Raw Materials Sales Market Share by Type (2020-2025)
Table 28. Global mRNA Vaccine Raw Materials Market Size (M USD) by Type (2020-2025)
Table 29. Global mRNA Vaccine Raw Materials Market Size Share by Type (2020-2025)
Table 30. Global mRNA Vaccine Raw Materials Price (USD/MT) by Type (2020-2025)
Table 31. Global mRNA Vaccine Raw Materials Sales (K MT) by Application
Table 32. Global mRNA Vaccine Raw Materials Market Size by Application
Table 33. Global mRNA Vaccine Raw Materials Sales by Application (2020-2025) & (K MT)
Table 34. Global mRNA Vaccine Raw Materials Sales Market Share by Application (2020-2025)
Table 35. Global mRNA Vaccine Raw Materials Market Size by Application (2020-2025) & (M USD)
Table 36. Global mRNA Vaccine Raw Materials Market Share by Application (2020-2025)
Table 37. Global mRNA Vaccine Raw Materials Sales Growth Rate by Application (2020-2025)
Table 38. Global mRNA Vaccine Raw Materials Sales by Region (2020-2025) & (K MT)
Table 39. Global mRNA Vaccine Raw Materials Sales Market Share by Region (2020-2025)
Table 40. Global mRNA Vaccine Raw Materials Market Size by Region (2020-2025) & (M USD)
Table 41. Global mRNA Vaccine Raw Materials Market Size Market Share by Region (2020-2025)
Table 42. North America mRNA Vaccine Raw Materials Sales by Country (2020-2025) & (K MT)
Table 43. North America mRNA Vaccine Raw Materials Market Size by Country (2020-2025) & (M USD)
Table 44. Europe mRNA Vaccine Raw Materials Sales by Country (2020-2025) & (K MT)
Table 45. Europe mRNA Vaccine Raw Materials Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific mRNA Vaccine Raw Materials Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific mRNA Vaccine Raw Materials Market Size by Region (2020-2025) & (M USD)
Table 48. South America mRNA Vaccine Raw Materials Sales by Country (2020-2025) & (K MT)
Table 49. South America mRNA Vaccine Raw Materials Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa mRNA Vaccine Raw Materials Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa mRNA Vaccine Raw Materials Market Size by Region (2020-2025) & (M USD)
Table 52. Global mRNA Vaccine Raw Materials Production (K MT) by Region(2020-2025)
Table 53. Global mRNA Vaccine Raw Materials Revenue (US$ Million) by Region (2020-2025)
Table 54. Global mRNA Vaccine Raw Materials Revenue Market Share by Region (2020-2025)
Table 55. Global mRNA Vaccine Raw Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America mRNA Vaccine Raw Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe mRNA Vaccine Raw Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan mRNA Vaccine Raw Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China mRNA Vaccine Raw Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Thermo Fisher Scientific Inc. Basic Information
Table 61. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product Overview
Table 62. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Thermo Fisher Scientific Inc. Business Overview
Table 64. Thermo Fisher Scientific Inc. SWOT Analysis
Table 65. Thermo Fisher Scientific Inc. Recent Developments
Table 66. Danaher Corporation Basic Information
Table 67. Danaher Corporation mRNA Vaccine Raw Materials Product Overview
Table 68. Danaher Corporation mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Danaher Corporation Business Overview
Table 70. Danaher Corporation SWOT Analysis
Table 71. Danaher Corporation Recent Developments
Table 72. Kaneka Eurogentec S.A. Basic Information
Table 73. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product Overview
Table 74. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Kaneka Eurogentec S.A. Business Overview
Table 76. Kaneka Eurogentec S.A. SWOT Analysis
Table 77. Kaneka Eurogentec S.A. Recent Developments
Table 78. BioSpring Basic Information
Table 79. BioSpring mRNA Vaccine Raw Materials Product Overview
Table 80. BioSpring mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. BioSpring Business Overview
Table 82. BioSpring Recent Developments
Table 83. GenScript Basic Information
Table 84. GenScript mRNA Vaccine Raw Materials Product Overview
Table 85. GenScript mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. GenScript Business Overview
Table 87. GenScript Recent Developments
Table 88. Aji Bio-Pharma Basic Information
Table 89. Aji Bio-Pharma mRNA Vaccine Raw Materials Product Overview
Table 90. Aji Bio-Pharma mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Aji Bio-Pharma Business Overview
Table 92. Aji Bio-Pharma Recent Developments
Table 93. Merck KGaA Basic Information
Table 94. Merck KGaA mRNA Vaccine Raw Materials Product Overview
Table 95. Merck KGaA mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Merck KGaA Business Overview
Table 97. Merck KGaA Recent Developments
Table 98. Aldevron Basic Information
Table 99. Aldevron mRNA Vaccine Raw Materials Product Overview
Table 100. Aldevron mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Aldevron Business Overview
Table 102. Aldevron Recent Developments
Table 103. Hongene Basic Information
Table 104. Hongene mRNA Vaccine Raw Materials Product Overview
Table 105. Hongene mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Hongene Business Overview
Table 107. Hongene Recent Developments
Table 108. WuXi Biologics Basic Information
Table 109. WuXi Biologics mRNA Vaccine Raw Materials Product Overview
Table 110. WuXi Biologics mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. WuXi Biologics Business Overview
Table 112. WuXi Biologics Recent Developments
Table 113. Asymchem Basic Information
Table 114. Asymchem mRNA Vaccine Raw Materials Product Overview
Table 115. Asymchem mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Asymchem Business Overview
Table 117. Asymchem Recent Developments
Table 118. Cosychem Basic Information
Table 119. Cosychem mRNA Vaccine Raw Materials Product Overview
Table 120. Cosychem mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Cosychem Business Overview
Table 122. Cosychem Recent Developments
Table 123. Novoprotein Basic Information
Table 124. Novoprotein mRNA Vaccine Raw Materials Product Overview
Table 125. Novoprotein mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Novoprotein Business Overview
Table 127. Novoprotein Recent Developments
Table 128. Vazyme Basic Information
Table 129. Vazyme mRNA Vaccine Raw Materials Product Overview
Table 130. Vazyme mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Vazyme Business Overview
Table 132. Vazyme Recent Developments
Table 133. Yeasen Basic Information
Table 134. Yeasen mRNA Vaccine Raw Materials Product Overview
Table 135. Yeasen mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Yeasen Business Overview
Table 137. Yeasen Recent Developments
Table 138. KACTUS Basic Information
Table 139. KACTUS mRNA Vaccine Raw Materials Product Overview
Table 140. KACTUS mRNA Vaccine Raw Materials Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. KACTUS Business Overview
Table 142. KACTUS Recent Developments
Table 143. Global mRNA Vaccine Raw Materials Sales Forecast by Region (2026-2033) & (K MT)
Table 144. Global mRNA Vaccine Raw Materials Market Size Forecast by Region (2026-2033) & (M USD)
Table 145. North America mRNA Vaccine Raw Materials Sales Forecast by Country (2026-2033) & (K MT)
Table 146. North America mRNA Vaccine Raw Materials Market Size Forecast by Country (2026-2033) & (M USD)
Table 147. Europe mRNA Vaccine Raw Materials Sales Forecast by Country (2026-2033) & (K MT)
Table 148. Europe mRNA Vaccine Raw Materials Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Asia Pacific mRNA Vaccine Raw Materials Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Asia Pacific mRNA Vaccine Raw Materials Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. South America mRNA Vaccine Raw Materials Sales Forecast by Country (2026-2033) & (K MT)
Table 152. South America mRNA Vaccine Raw Materials Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa mRNA Vaccine Raw Materials Sales Forecast by Country (2026-2033) & (Units)
Table 154. Middle East and Africa mRNA Vaccine Raw Materials Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Global mRNA Vaccine Raw Materials Sales Forecast by Type (2026-2033) & (K MT)
Table 156. Global mRNA Vaccine Raw Materials Market Size Forecast by Type (2026-2033) & (M USD)
Table 157. Global mRNA Vaccine Raw Materials Price Forecast by Type (2026-2033) & (USD/MT)
Table 158. Global mRNA Vaccine Raw Materials Sales (K MT) Forecast by Application (2026-2033)
Table 159. Global mRNA Vaccine Raw Materials Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of mRNA Vaccine Raw Materials
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccine Raw Materials Market Size (M USD), 2024-2033
Figure 5. Global mRNA Vaccine Raw Materials Market Size (M USD) (2020-2033)
Figure 6. Global mRNA Vaccine Raw Materials Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccine Raw Materials Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Vaccine Raw Materials Product Life Cycle
Figure 13. mRNA Vaccine Raw Materials Sales Share by Manufacturers in 2024
Figure 14. Global mRNA Vaccine Raw Materials Revenue Share by Manufacturers in 2024
Figure 15. mRNA Vaccine Raw Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market mRNA Vaccine Raw Materials Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine Raw Materials Revenue in 2024
Figure 18. Industry Chain Map of mRNA Vaccine Raw Materials
Figure 19. Global mRNA Vaccine Raw Materials Market PEST Analysis
Figure 20. Global mRNA Vaccine Raw Materials Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Vaccine Raw Materials Market Share by Type
Figure 27. Sales Market Share of mRNA Vaccine Raw Materials by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Vaccine Raw Materials by Type in 2024
Figure 29. Market Size Share of mRNA Vaccine Raw Materials by Type (2020-2025)
Figure 30. Market Size Share of mRNA Vaccine Raw Materials by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Vaccine Raw Materials Market Share by Application
Figure 33. Global mRNA Vaccine Raw Materials Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Vaccine Raw Materials Sales Market Share by Application in 2024
Figure 35. Global mRNA Vaccine Raw Materials Market Share by Application (2020-2025)
Figure 36. Global mRNA Vaccine Raw Materials Market Share by Application in 2024
Figure 37. Global mRNA Vaccine Raw Materials Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Vaccine Raw Materials Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Vaccine Raw Materials Market Size Market Share by Region (2020-2025)
Figure 40. North America mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America mRNA Vaccine Raw Materials Sales Market Share by Country in 2024
Figure 43. North America mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Vaccine Raw Materials Market Size Market Share by Country in 2024
Figure 45. U.S. mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Vaccine Raw Materials Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Vaccine Raw Materials Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Vaccine Raw Materials Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Vaccine Raw Materials Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe mRNA Vaccine Raw Materials Sales Market Share by Country in 2024
Figure 53. Europe mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Vaccine Raw Materials Market Size Market Share by Country in 2024
Figure 55. Germany mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Vaccine Raw Materials Sales and Growth Rate (K MT)
Figure 66. Asia Pacific mRNA Vaccine Raw Materials Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Vaccine Raw Materials Market Size Market Share by Region in 2024
Figure 68. China mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Vaccine Raw Materials Sales and Growth Rate (K MT)
Figure 79. South America mRNA Vaccine Raw Materials Sales Market Share by Country in 2024
Figure 80. South America mRNA Vaccine Raw Materials Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Vaccine Raw Materials Market Size Market Share by Country in 2024
Figure 82. Brazil mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Vaccine Raw Materials Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa mRNA Vaccine Raw Materials Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Vaccine Raw Materials Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Vaccine Raw Materials Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Vaccine Raw Materials Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa mRNA Vaccine Raw Materials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Vaccine Raw Materials Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Vaccine Raw Materials Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe mRNA Vaccine Raw Materials Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan mRNA Vaccine Raw Materials Production (K MT) Growth Rate (2020-2025)
Figure 106. China mRNA Vaccine Raw Materials Production (K MT) Growth Rate (2020-2025)
Figure 107. Global mRNA Vaccine Raw Materials Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global mRNA Vaccine Raw Materials Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global mRNA Vaccine Raw Materials Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global mRNA Vaccine Raw Materials Market Share Forecast by Type (2026-2033)
Figure 111. Global mRNA Vaccine Raw Materials Sales Forecast by Application (2026-2033)
Figure 112. Global mRNA Vaccine Raw Materials Market Share Forecast by Application (2026-2033)